Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yanqiu Han
Observed names:
Yan-Qiu Han,
Yan-Qiu Han#,
Yan‐qiu Han
Institutions:
First Affiliated Hospital of Soochow University,
Inner Mongolia Medical University
Observed institutions:
Inner Mongolia Medical College Hospital,
First Affiliated Hospital of Soochow University,
Inner Mongolia Medical University
ORCID:
0000-0002-2658-0803
Observed ORCID:
0000-0002-2658-0803
OpenAlex ID:
A5064230501
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy
2024
·
Xiaoshuai Zhang
, Bingcheng Liu
, et al.
·
Blood
·
19
Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms
2023
·
Mei Bao
, Mengyu Zhang
, et al.
·
Acta Haematologica
·
8
[Drug susceptibility and homologous analysis on Corynebacterium striatum strains isolated from inpatients].
2014
·
Junrui Wang
, Xiaoli Du
, et al.
·
PubMed
·
8
A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML
2024
·
Zhibo Zhang
, Jia Yin
, et al.
·
Blood Advances
·
6
PDF
Validation of the imatinib-therapy failure model
2023
·
Xiaoshuai Zhang
, Robert Peter Gale
, et al.
·
Leukemia
·
4
Olverembatinib-Based Therapy in Patients with Philadelphia Chromosome-Positive Acute Leukemia: A Multi-Centre Retrospective Study from China
2024
·
Mei Bao
, Jian Huang
, et al.
·
Blood
·
3
Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial
2024
·
Shenmiao Yang
, Haiwen Huang
, et al.
·
Annals of Hematology
·
2
PDF
Imatinib compared with second‐generation tyrosine kinase‐inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase
2023
·
Sen Yang
, Xiaoshuai Zhang
, et al.
·
American Journal of Hematology
·
2
PDF
Proteomics as a theranostic compass in BCR::ABL1-negative myeloproliferative neoplasms: Integrating biomarker discovery with therapeutic stratification
2026
·
Jing Zhang
, Yan-Qiu Han
·
Critical Reviews in Oncology/Hematology
·
1
ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming
2025
·
Lan Yang
, Yanqiu Han
·
Frontiers in Oncology
·
1
PDF
Pb1929: Efficacy and Safety of Acalabrutinib in Chinese Patients With Relapsed/refractory Chronic Lymphocytic Leukemia: an Open-label, Multicenter Phase 1/2 Trial
2023
·
Shenmiao Yang
, Haiwen Huang
, et al.
·
HemaSphere
·
1
Pb1829: Quercetin Exhibits Anti-leukemia Effects Via Regulation of Metabolic Reprogramming
2023
·
Jing Zhang
, Rui-Hua Huan
, et al.
·
HemaSphere
·
1
Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional Survey
2025
·
Junling Zhuang
, Hongxia Shi
, et al.
·
Acta Haematologica
Olverembatinib 30 Mg Versus 40 Mg Every Other Day (QOD) in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP): A Multi-Center Propensity Score-Matched Analysis
2024
·
Xiaoshuai Zhang
, Lu Yu
, et al.
·
Blood
Acalabrutinib in Chinese Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: 24-Month Efficacy and Safety Results from an Open-Label, Multicenter Phase 1/2 Trial
2024
·
Shenmiao Yang
, Haiwen Huang
, et al.
·
Blood
Olverembatinib-Therapy in Patients with Accelerated-Phase Chronic Myeloid Leukaemia: A Multi-Centre Retrospective Study from China
2024
·
Mengyao Yuan
, Li Zhou
, et al.
·
Blood
[Halving Time of BCR-ABL Transcripts as a Precise Predictor for Deep Molecular Response in Patients with Chronic Myeloid Leukemia Treated with TKI].
2024
·
Lan Yang
, Li-Xia Cao
, et al.
·
PubMed
[Primary Extranodal Diffuse Large B-Cell Lymphoma in the Rituximab Era: a Single-Center Retrospective Analysis].
2024
·
Lan Yang
, Li-Xia Cao
, et al.
·
PubMed
Acalabrutinib in Chinese Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): 12-Month Efficacy and Safety Results from an Open-Label, Multicenter Phase 1/2 Trial
2023
·
Shenmiao Yang
, Haiwen Huang
, et al.
·
Blood
PDF
Pb2482: Roxadustat Suppresses Adipogenesis in Human Bmmsc and Promotes Epo Production Via Regulation of Hif Signaling Pathways
2023
·
Jing Zhang
, Hui-Juan Ren
, et al.
·
HemaSphere
Higher prevalence of multi-antimicrobial resistant Bacteroides spp. strains isolated at a tertiary teaching hospital, China
2019
·
Yanyan Wang
, Yanqiu Han
, et al.
PDF
Truncated Plasmodium berghei putative secreted ookinete protein 7 induces transmission-blocking immunity.
2019
·
Wen‐Qi Zheng
, Junrui Wang
, et al.
·
Zhongguo jishengchongxue yu jishengchongbing zazhi
Molecular epidemiological characteristics of human derived Brucella isolated in Hohhot
2017
·
Yanyan Wang
, Lulei Zhou
, et al.
·
Chin J Endemiol
Show more works
View as search
Works count:
23
Citation count:
56
H-index:
4
I10-index:
1
Year
Topic
Type